P42866 (OPRM_MOUSE) Mus musculus (Mouse)
Mu-type opioid receptor UniProtKBInterProSTRINGInteractive Modelling
398 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6; Isoform 7; Isoform 8; Isoform 9; Isoform 10; Isoform 11; Isoform 12; Isoform 13; Isoform 14; Isoform 15; Isoform 16; Isoform 17; Isoform 18; Isoform 19);
2 identical sequences: Mus spicilegus: A0A8C6I3Q0; Mus caroli: A0A6P5QNL8
It is possible new templates exist for this target since these models were created.
Available Structures
13 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal structure of active mu-opioid receptor bound to the agonist BU72 |
Heteromer | 2×OLC; 1×CLR; 1×PO4; 2×P6G; 1×VF1; | ||||
| Assess | ||||||
| Re-refined model of active mu-opioid receptor (PDB 5c1m) as an adduct with BU72 |
Heteromer | 2×OLC; 1×CLR; 1×PO4; 1×P6G; 1×PG4; 1×VF1; | ||||
| Assess | ||||||
| CryoEM Structure of Inactive MOR Bound to Alvimopan and Mb6 |
Heteromer | 1×NG0; | ||||
| Assess | ||||||
| Structure of the mu opioid receptor bound to the antagonist nanobody NbE |
Heteromer | |||||
| Assess | ||||||
| C5guano-uOR-Gi-scFv16 |
Heteromer P59768; P62873; P63096; | 1×L0X; | ||||
| Assess | ||||||
| FH210 bound Mu Opioid Receptor-Gi Protein Complex |
Heteromer P59768; P62873; P63096; | 1×8RI; | ||||
| Assess | ||||||
| C6-guano bound Mu Opioid Receptor-Gi Protein Complex |
Heteromer P59768; P62873; P63096; | 1×KZR; | ||||
| Assess | ||||||
| CryoEM structure of mu-opioid receptor - Gi protein complex bound to lofentanil (LFT) |
Heteromer P59768; P62873; P63096; | 1×EID; | ||||
| Assess | ||||||
| Mu Opioid Receptor-Gi Protein Complex |
Heteromer P59768; P62873; P63096; | |||||
| Assess | ||||||
| Mu Opioid Receptor-Gi Protein Complex |
Heteromer P59768; P62873; P63096; | |||||
| Assess | ||||||
| CryoEM structure of mu-opioid receptor - Gi protein complex bound to mitragynine pseudoindoxyl (MP) |
Heteromer P59768; P62873; P63096; | 1×EIG; 2×CLR; | ||||
| Assess | ||||||
| PZM21 bound Mu Opioid Receptor-Gi Protein Complex |
Heteromer P59768; P62873; P63096; | 1×8QY; | ||||
| Assess | ||||||
| Crystal structure of the mu-opioid receptor bound to a morphinan antagonist | homo-2-mer | 2×BF0; 24×SO4; 2×CLR; 4×MPG; 2×1PE; 2×CL; | ||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8f7q.1.A | monomer | 0.74 | 2×CLR; | 93.98 | ||
| Assess | ||||||
18 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 8f7q.1.A | monomer | 0.73 | 2×CLR; | 93.98 | |
| Assess | ||||||
| Isoform 3 | 8f7q.1.A | monomer | 0.74 | 2×CLR; | 93.98 | |
| Assess | ||||||
| Isoform 4 | 8f7q.1.A | monomer | 0.73 | 2×CLR; | 93.98 | |
| Assess | ||||||
| Isoform 5 | 8f7q.1.A | monomer | 0.74 | 2×CLR; | 93.98 | |
| Assess | ||||||
| Isoform 6 | 8f7q.1.A | monomer | 0.74 | 2×CLR; | 93.98 | |
| Assess | ||||||
| Isoform 7 | 8f7q.1.A | monomer | 0.73 | 2×CLR; | 93.98 | |
| Assess | ||||||
| Isoform 8 | 8f7q.1.A | monomer | 0.74 | 2×CLR; | 93.98 | |
| Assess | ||||||
| Isoform 9 | 8f7q.1.A | monomer | 0.72 | 2×CLR; | 93.98 | |
| Assess | ||||||
| Isoform 10 | 8f7q.1.A | monomer | 0.73 | 2×CLR; | 93.98 | |
| Assess | ||||||
| Isoform 11 | 8f7q.1.A | monomer | 0.73 | 2×CLR; | 93.98 | |
| Assess | ||||||
| Isoform 12 | 8f7q.1.A | monomer | 0.74 | 2×CLR; | 93.98 | |
| Assess | ||||||
| Isoform 13 | 8f7q.1.A | monomer | 0.73 | 2×CLR; | 93.98 | |
| Assess | ||||||
| Isoform 14 | 8f7q.1.A | monomer | 0.72 | 2×CLR; | 97.25 | |
| Assess | ||||||
| Isoform 15 | 8f7q.1.A | monomer | 0.72 | 2×CLR; | 97.25 | |
| Assess | ||||||
| Isoform 16 | 8f7q.1.A | monomer | 0.72 | 2×CLR; | 97.25 | |
| Assess | ||||||
| Isoform 17 | 8f7q.1.A | monomer | 0.73 | 2×CLR; | 93.98 | |
| Assess | ||||||
| Isoform 18 | 8f7q.1.A | monomer | 0.73 | 2×CLR; | 93.98 | |
| Assess | ||||||
| Isoform 19 | 8f7q.1.A | monomer | 0.74 | 2×CLR; | 93.98 | |
| Assess | ||||||